What is NDC 70095-026?

70095-026 is the product NDC for Desmopressin Acetate, Desmopressin acetate 4 ug/mL injection, solution, listed with the FDA by Sun Pharmaceutical Industries Limited. It has 1 package NDC, shown above in 10- and 11-digit form.

Sun Pharmaceutical Industries Limited, NDC labeler code 70095. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Desmopressin Acetate?

48 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Desmopressin Acetate NDC 70095-026

NDC codes

FDA NDC Directory

Product NDC (as listed)70095-026Labeler and product segments. Claims need a package NDC.

Product NDC at billing width70095-0026Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
70095-026-02	7009500260270095002602	10 VIAL, SINGLE-DOSE in 1 CARTON (70095-026-02) / 1 mL in 1 VIAL, SINGLE-DOSE (70095-026-01)Marketed from Apr 3, 2023

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Desmopressin Acetate
Generic name (nonproprietary): desmopressin acetate
Active ingredients: Desmopressin acetate — 4 ug/mL
Dosage form: Injection, Solution
Route: Intravenous, Subcutaneous
Labeler: Sun Pharmaceutical Industries LimitedNDC labeler code 70095
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 216922
Marketing start: Apr 3, 2023
Listing expires: Dec 31, 2026
Other FDA classes: Increased Coagulation Factor VIII Activity (Physiologic effect)Increased Coagulation Factor VIII Concentration (Physiologic effect)Vasopressins (Chemical structure)
Identifiers: Product ID 70095-026_353c7624-9af3-4103-9223-af53bc7371a5SPL ID 353c7624-9af3-4103-9223-af53bc7371a5SPL set ID cdec2cc2-4fd9-474e-884f-d0599e40948fRxCUI 1723232UNII XB13HYU18U
Pharmacologic class: Factor VIII Activator; Vasopressin Analog

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N470095002602 followed by a unit qualifier and the quantity

Package 70095-0026-02. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Apr 6, 2023. This label includes a boxed warning.

Indications (excerpt from the label)

Desmopressin acetate injection is a vasopressin analog used for: Central Diabetes Insipidus - as antidiuretic replacement therapy in the management of central (cranial) diabetes insipidus and for the management of the temporary polyuria and polydipsia following head trauma or surgery in the pituitary region. ( 1.1 ) Hemophilia A- for patients with factor VIII coagulant activity levels greater than 5% to maintain hemostasis during surgical procedures and postoperatively or reduce bleeding with episodes of spontaneous or traumatic injuries such as hemarthroses, intramuscular hematomas, or mucosal bleeding. ( 1.2 ) von Willebrand’s disease (Type I) - for patients with mild to moderate disease w…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 70095-026

What is NDC 70095-026?: 70095-026 is the product NDC for Desmopressin Acetate, Desmopressin acetate 4 ug/mL injection, solution, listed with the FDA by Sun Pharmaceutical Industries Limited. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Desmopressin Acetate.
What is the active ingredient?: Desmopressin acetate.
Who is the labeler?: Sun Pharmaceutical Industries Limited, NDC labeler code 70095. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Desmopressin Acetate?: 48 other product NDCs are listed under this name. See all Desmopressin Acetate NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Desmopressin Acetate NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Desmopressin Acetate	Desmopressin acetate 4 ug/mL	Injection, SolutionIntravenous, Subcutaneous	The J. Molner Company LLC	83148-126	83148-0126-01
Desmopressin Acetate	Desmopressin acetate 4 ug/mL	Injection, SolutionIntravenous, Subcutaneous	Armas Pharmaceuticals Inc.	72485-523	72485-0523-10
Desmopressin Acetate	Desmopressin acetate 40 ug/10mL	Injection, SolutionIntravenous, Subcutaneous	Armas Pharmaceuticals Inc.	72485-524	72485-0524-01
Desmopressin Acetate	Desmopressin acetate .1 mg/1	TabletOral	REMEDYREPACK INC.	70518-4612	70518-4612-00
Desmopressin Acetate	Desmopressin acetate 4 ug/mL	Injection, SolutionIntravenous	Caplin Steriles Limited	65145-183	65145-0183-10
Desmopressin Acetate	Desmopressin acetate 4 ug/mL	Injection, SolutionIntravenous	Caplin Steriles Limited	65145-184	65145-0184-01
Desmopressin acetate	Desmopressin acetate 4 ug/mL	InjectionIntravenous, Subcutaneous	Meitheal Pharmaceuticals Inc.	71288-440	71288-0440-02
Desmopressin acetate	Desmopressin acetate 4 ug/mL	InjectionIntravenous, Subcutaneous	Meitheal Pharmaceuticals Inc.	71288-441	71288-0441-10
Desmopressin Acetate	Desmopressin acetate .1 mg/mL	SolutionNasal	Oceanside Pharmaceuticals	68682-342	68682-0342-05
Desmopressin Acetate	Desmopressin acetate 4 ug/mL	Injection, SolutionIntravenous, Subcutaneous	XGen Pharmaceuticals DJB, Inc.	39822-6200	39822-6200-02

All 49 Desmopressin Acetate NDCs

Other NDCs under ANDA 216922

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 216922
Product	Strength	Form · route	Labeler	Product NDC
Desmopressin Acetate	Desmopressin acetate 4 ug/mL	Injection, SolutionIntravenous, Subcutaneous	Fresenius Kabi USA, LLC	65219-293
Desmopressin Acetate	Desmopressin acetate 4 ug/mL	Injection, SolutionIntravenous, Subcutaneous	Gland Pharma Limited	68083-550